Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14051 - 14075 of 14542 in total
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Displaying drugs 14051 - 14075 of 14542 in total